Ceforanide
Names | |
---|---|
IUPAC name
| |
Clinical data | |
Routes of use | Intramuscular |
External links | |
AHFS/Drugs.com | International Drug Names |
US NLM | Ceforanide |
Pharmacokinetics | |
Protein binding | 80.6% |
Metabolism | Nil |
Elimination half-life | 2.6 to 2.98 hours |
Excretion | Kidney |
Identifiers | |
CAS Number |
|
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
NIAID ChemDB | |
ATC code | |
Chemical and physical data | |
Formula | C20H21N7O6S2 |
Molar mass | 519.55 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Ceforanide is an antibiotic.[1]
It is in the second-generation cephalosporin family of medications.[1]
See also
References
- 1 2 Beauduy, Camille E.; Winston, Lisa G. (2020). "43. Beta-lactam and other cell wall - & membrane - active antibiotics". In Katzung, Bertram G.; Trevor, Anthony J. (eds.). Basic and Clinical Pharmacology (15th ed.). New York: McGraw-Hill. p. 833. ISBN 978-1-260-45231-0. Archived from the original on 2021-10-10. Retrieved 2021-11-30.
External links
- Crowle A, Sbarbaro J, May M (1988). "Effects of isoniazid and of ceforanide against virulent tubercle bacilli in cultured human macrophages". Tubercle. 69 (1): 15–25. doi:10.1016/0041-3879(88)90036-0. PMID 3140456.
- Campoli-Richards D, Lackner T, Monk J (1987). "Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy". Drugs. 34 (4): 411–37. doi:10.2165/00003495-198734040-00001. PMID 3315624.
- Cone L, Barton S, Woodard D (1987). "Treatment of scleroma with ceforanide". Arch Otolaryngol Head Neck Surg. 113 (4): 374–6. doi:10.1001/archotol.1987.01860040036012. PMID 3814386.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.